Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUBLIVAC rush-in versus conventional initial phase safety study
2004-004618-18Phase 4Completed
- Sponsor
- HAL Allergy Group
- Start
- Mar 2005
- Countries
- 1
01
Overview
Phase 4, randomised trial of birch pollen extract in atopic disease (2 arms), sponsored by HAL Allergy Group. Started Mar 2005; status: completed.
02
Drugs
birch pollen extract
03
Conditions
atopic disease
Beyond the preview
Go deeper on 2004-004618-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004618-18.